Levobupivacaine During Cholecystectomy

The purpose of this study is to determine the effects of intraperitoneal administration of levobupivacaine on pain after laparoscopic cholecystectomy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cholelithiasis Biliary Tract Diseases Digestive System Diseases Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Ege University School of Medicine

Izmir, 35100, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

cholelithiasis
chronic cholecystitis

Exclusion criteria

hypersensitivity to local anesthetics
acute cholecystitis
morbid obesity

Treatment and study plan

Levobupivacaine

Drug

intraperitoneal administration of levobupivacaine on pain after laparoscopic cholecystectomy

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Ege University

Other

Registry information

Official study title

Effects of Intraperitoneal Levobupivacaine on Pain After Laparoscopic Cholecystectomy: A Prospective, Randomized, Double-Blinded Study

Important dates

First posted: Feb 4, 2009
Registry last updated: Feb 4, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed